EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the Antitumor Efficacy of Human Papillomavirus Type 16 E7-Affitoxin in C57BL/6JNifdc Mice Bearing TC-1 Tumors

Hua Zhu, Zhihui Zhang, Jingwei Ye, Hongshuai Yang, Jingjie Lin, Xinlei Cao, Lifang Zhang, Yubing Chen, Pengfei Jiang iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.5c01013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Hua Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P. R. China. Hauptthemen laut MEDLINE: Papillomavirus E7 Proteins, Human papillomavirus 16, Antineoplastic Agents, Uterine Cervical Neoplasms. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wenzhou Medical University, Wenzhou Municipal Science and Technology Bureau, National College Students Innovation and Entrepreneurship Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human papillomavirus (HPV) associated cancers pose a significant global health threat, with HPV 16 being the most common causative type. Current treatments often lack specificity and cause severe side effects. In a previous study, we developed an HPV16 E7 targeted therapeutic agent, ZHPV16E7 affitoxin384, which effectively inhibited tumor growth in immunodeficient nude mice bearing HPV16-positive cervical tumors. In this study, we further evaluated the antitumor efficacy of ZHPV16E7 affitoxin384 in immunocompetent C57BL/6JNifdc mice bearing TC-1 tumors. ZHPV16E7 affitoxin384 had demonstrated specific binding to HPV16 E7 in TC-1 cells, significantly inhibiting their proliferation and promoting apoptosis both in vitro and in vivo. In C57BL/6JNifdc mice, ZHPV16E7 affitoxin384 effectively suppressed TC-1 tumor growth, with a therapeutic effect comparable to that of cisplatin. Acute toxicity tests indicated dose-dependent toxicity, but no significant organ damage or effects on liver/kidney function or blood parameters were observed at tested doses. This study provides robust evidence supporting ZHPV16E7 affitoxin384 as a promising targeted therapy for HPV16-induced cancers, highlighting its potential for future clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus E7 ProteinsHuman papillomavirus 16Antineoplastic AgentsUterine Cervical NeoplasmsAnimalsMiceMice, Inbred C57BLFemaleHumansApoptosisCell Line, TumorCell ProliferationXenograft Model Antitumor AssaysPapillomavirus Infections

Stichwörter der Autor:innen

C57BL/6JNifdc miceHPV16TC-1 tumoraffitoxinantitumor targeted therapy

Substanzen

Papillomavirus E7 Proteinsoncogene protein E7, Human papillomavirus type 16Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P. R. China.
  • Department of Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325035, China.
  • Department of Clinical Laboratory, Yantai Affiliated Hospital of Binzhou Medical University, Yantai 264100, China.

ORCID-Profile: Pengfei Jiang

Förderung

  • Wenzhou Medical University
  • Wenzhou Municipal Science and Technology Bureau
  • National College Students Innovation and Entrepreneurship Training Program
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Zhu, H., Zhang, Z., Ye, J., Yang, H., Lin, J., Cao, X., Zhang, L., Chen, Y., & Jiang, P. (2025). Evaluation of the Antitumor Efficacy of Human Papillomavirus Type 16 E7-Affitoxin in C57BL/6JNifdc Mice Bearing TC-1 Tumors. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01013

Vancouver

Zhu H, Zhang Z, Ye J, Yang H, Lin J, Cao X, et al. Evaluation of the Antitumor Efficacy of Human Papillomavirus Type 16 E7-Affitoxin in C57BL/6JNifdc Mice Bearing TC-1 Tumors. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c01013

BibTeX
@article{Zhu2025,
  author = {Zhu, Hua and Zhang, Zhihui and Ye, Jingwei and Yang, Hongshuai and Lin, Jingjie and Cao, Xinlei and Zhang, Lifang and Chen, Yubing and Jiang, Pengfei},
  title = {Evaluation of the Antitumor Efficacy of Human Papillomavirus Type 16 E7-Affitoxin in C57BL/6JNifdc Mice Bearing TC-1 Tumors},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.5c01013}
}
Kostenlos starten →